Monte Rosa Therapeutics Announces $25 Million Registered Direct Offering, Priced At- the-Market Under Nasdaq Rules tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Pasithea Therapeutics Corp. Announces Pricing of a $30.4 Million Private Placement Priced At a Premium to the Market Under Nasdaq Rules Miami Beach, FL, November.